Meeting the Gastrointestinal Needs of a Culturally and Linguistically Diverse Patient Population

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 2, 2011, Pages 106-109

  Marquez, Evelyn ^a   Gupta, Samir ^a   Cryer, Byron ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN;

AFRICAN AMERICAN; ARTICLE; BODY MASS; CANCER RISK; CANCER SCREENING; CAUCASIAN; COLONOSCOPY; COLORECTAL CANCER; CULTURAL FACTOR; DISEASE TRANSMISSION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HISPANIC; HUMAN; IMMUNE RESPONSE; INFECTION RISK; KINETICS; LANGUAGE ABILITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PREVALENCE; RACE DIFFERENCE; RISK ASSESSMENT; SOCIAL STATUS; TREATMENT DURATION; TREATMENT RESPONSE; UNITED STATES; VIRAL CLEARANCE;

AGE FACTORS; COLONOSCOPY; COLORECTAL NEOPLASMS; COMMUNICATION BARRIERS; CONTINENTAL POPULATION GROUPS; CULTURE; DRUG RESISTANCE, VIRAL; EARLY DIAGNOSIS; FECES; GENOTYPE; HEALTH SERVICES NEEDS AND DEMAND; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOCHEMISTRY; MASS SCREENING; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PARTICIPATION; REAGENT KITS, DIAGNOSTIC; RISK ASSESSMENT; UNITED STATES;

EID: 78751683388     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2010.10.034     Document Type: Article

References (9)

1. Jeffers L.J. Treating hepatitis C in African Americans. Liver Int 2007, 27:313-322.
2. Rodriguez-Torres M., Jeffers L.J., Sheikh M.Y., et al. Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C. N Engl J Med 2009, 360:257-267.
3. Ge D., Fellay J., Thompson A.J., et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009, 461:399-401.
4. Rim S.H., Seeff L., Ahmed F., et al. Colorectal cancer incidence in the United States, 19992004: an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology and End Results Program. Cancer 2009, 115:1967-1976.
5. Percac-Lima S., Grant R.W., Green A.R., et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med 2009, 24:211-217.
6. Lieberman D.A., Holub J.L., Moravec M.D., et al. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA 2008, 300:1417-1422.
7. Penn E., Garrow D., Romagnuolo J. Influence of race and sex on prevalence and recurrence of colon polyps. Arch Intern Med 2010, 170:1127-1132.
8. DeBourcy A.C., Lichtenberger S., Felton S., et al. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med 2008, 23:169-174.
9. Palmer R.C., Midgette L.A., Mullan I.D. Colorectal cancer screening preferences among African Americans: which screening test is preferred?. J Cancer Educ 2010, 25:577-581.